Two different types of tandem sequences mediate the overexpression of TinCYP51B in azole-resistant Trichophyton indotineae
Antimicrobial Agents and Chemotherapy · 2023
DOI: 10.1128/aac.00933-23 ↗Kurz gefasst
Fachartikel in der Zeitschrift Antimicrobial Agents and Chemotherapy, 2023. Verfasst von Tsuyoshi Yamada und 7 weiteren Autor:innen. Beteiligte Einrichtung: Teikyo University Institute of Medical Mycology , Tokyo, Japan. Hauptthemen laut MEDLINE: Antifungal Agents, Arthrodermataceae. Die Arbeit wurde bisher 39-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Nihon Nohyaku Co., Ltd..
Abstract (Originalsprache)
Trichophyton indotineae is an emerging dermatophyte that causes severe tinea corporis and tinea cruris. Numerous cases of terbinafine- and azole-recalcitrant T. indotineae -related dermatophytosis have been observed in India over the past decade, and cases are now being recorded worldwide. Whole genome sequencing of three azole-resistant strains revealed a variable number of repeats of a 2,404 base pair (bp) sequence encoding TinCYP51B in tandem specifically at the CYP51B locus position. However, many other resistant strains (itraconazole MIC ≥0.25 µg/mL; voriconazole MIC ≥0.25 µg/mL) did not contain such duplications. Whole-genome sequencing of three of these strains revealed a variable number of 7,374 bp tandem repeat blocks harboring TinCYP51B . Consequently, two types of T. indotineae azole-resistant strains were found to host TinCYP51B in tandem sequences (type I with 2,404 bp TinCYP51B blocks and type II with 7,374 bp TinCYP51B blocks). Using the CRISPR/Cas9 genome-editing tool, the copy number of TinCYP51B within the genome of types I and II strains was brought back to a single copy. The azole susceptibility of these modified strains was similar to that of strains without TinCYP51B duplication, showing that azole resistance in T. indotineae strains is mediated by one of two types of TinCYP51B amplification. Type II strains were prevalent among 32 resistant strains analyzed using a rapid and reliable PCR test.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Teikyo University Institute of Medical Mycology , Tokyo, Japan.
- Asia International Institute of Infectious Disease Control, Teikyo University , Tokyo, Japan.
- Nihon Nohyaku Co., Ltd. , Tokyo, Japan.
- Department of Dermatology, Centre Hospitalier Universitaire Vaudois , Lausanne, Switzerland.
- Faculty of Biology and Medicine, University of Lausanne , Lausanne, Switzerland.
- Swiss-Prot group, SIB Swiss Institute of Bioinformatics , Geneva, Switzerland.
ORCID-Profile: Tsuyoshi Yamada, Yun-Tsan Chang, Emmanuella Guenova, Marc Feuermann, Michel Monod
Förderung
- Nihon Nohyaku Co., Ltd.
Zitieren
APA
Yamada, T., Maeda, M., Nagai, H., Salamin, K., Chang, Y. T., Guenova, E., Feuermann, M., & Monod, M. (2023). Two different types of tandem sequences mediate the overexpression of TinCYP51B in azole-resistant Trichophyton indotineae. Antimicrobial Agents and Chemotherapy. https://doi.org/10.1128/aac.00933-23
Vancouver
Yamada T, Maeda M, Nagai H, Salamin K, Chang YT, Guenova E, et al. Two different types of tandem sequences mediate the overexpression of TinCYP51B in azole-resistant Trichophyton indotineae. Antimicrobial Agents and Chemotherapy. 2023. doi:10.1128/aac.00933-23
BibTeX
@article{Yamada2023,
author = {Yamada, Tsuyoshi and Maeda, Mari and Nagai, Hiroaki and Salamin, Karine and Chang, Yun-Tsan and Guenova, Emmanuella and Feuermann, Marc and Monod, Michel},
title = {Two different types of tandem sequences mediate the overexpression of TinCYP51B in azole-resistant Trichophyton indotineae},
journal = {Antimicrobial Agents and Chemotherapy},
year = {2023},
doi = {10.1128/aac.00933-23}
}
EUVIMED